InsiderPulse| Trade Date | Filed | Owner | Role | Type | Shares | Price | Value | Owned After | ||
|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-22 | 2026-02-13 | Tempus AI, Inc. | 10% Owner | Purchase | 28.0K | $8.93 | $250K | 13.04M | View ↗ | |
| 2025-12-19 | 2026-02-13 | Tempus AI, Inc. | 10% Owner | Purchase | 29.6K | $8.39 | $249K | 13.01M | View ↗ | |
| 2025-12-18 | 2026-02-13 | Tempus AI, Inc. | 10% Owner | Purchase | 31.4K | $7.91 | $249K | 12.98M | View ↗ | |
| 2025-12-17 | 2026-02-13 | Tempus AI, Inc. | 10% Owner | Purchase | 31.6K | $7.86 | $249K | 12.95M | View ↗ | |
| 2025-11-25 | 2026-02-13 | Tempus AI, Inc. | 10% Owner | Purchase | 23.6K | $10.62 | $251K | 12.92M | View ↗ |
No financial data available for PSNL.
Company may not file with SEC or CIK is unresolved.
How The Personalis (PSNL) Story Is Shifting With Cautious Targets And Execution Risks
Personalis to Announce First Quarter 2026 Financial Results
Personalis Highlights Clinical Impact of Ultrasensitive ctDNA Monitoring and New Therapy Resistance Tracking at AACR 2026
Personalis and Collaborators to Highlight Ultrasensitive ctDNA Data and New Therapy Resistance Tracking Capabilities at AACR 2026